OTC Markets EXMKT - Delayed Quote USD

Veradigm Inc. (MDRX)

Compare
10.00 -0.30 (-2.91%)
At close: December 13 at 3:58:18 PM EST
Loading Chart for MDRX
DELL
  • Previous Close 10.30
  • Open 10.25
  • Bid --
  • Ask --
  • Day's Range 9.06 - 10.25
  • 52 Week Range 5.01 - 11.80
  • Volume 64,916
  • Avg. Volume 338,498
  • Market Cap (intraday) 1.076B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 10.99
  • EPS (TTM) 0.91
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Oct 7, 2008
  • 1y Target Est 12.75

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

veradigm.com

8,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MDRX

View More

Performance Overview: MDRX

Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MDRX
4.67%
S&P 500
26.86%

1-Year Return

MDRX
1.21%
S&P 500
30.31%

3-Year Return

MDRX
43.44%
S&P 500
28.42%

5-Year Return

MDRX
0.50%
S&P 500
90.97%

Compare To: MDRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDRX

View More

Valuation Measures

Annual
As of 11/7/2024
  • Market Cap

    1.08B

  • Enterprise Value

    1.08B

  • Trailing P/E

    11.05

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    0.49

  • Enterprise Value/EBITDA

    2.49

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.97%

  • Return on Assets (ttm)

    2.16%

  • Return on Equity (ttm)

    8.93%

  • Revenue (ttm)

    1.53B

  • Net Income Avi to Common (ttm)

    115.91M

  • Diluted EPS (ttm)

    0.91

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    492.6M

  • Total Debt/Equity (mrq)

    18.59%

  • Levered Free Cash Flow (ttm)

    155.57M

Research Analysis: MDRX

View More

Company Insights: MDRX

Research Reports: MDRX

View More

People Also Watch